LATEST NEWS
Antibody Treats Solid Tumors By Targeting Micro-Environment
The unexpected finding that EphA3 is highly expressed in the tumor microenvironment could lead to a new treatment for blood malignancies.
Fosun Commits US$111 Million To Partnership With Public Hospital
The partnership between Fosun and Taizhou Muncipal Hospital will add approximately 2,000 new hospital beds to serve the residents of Taizhou.
The Language Of Science Education: Between Two Trends
Saleh Al-Shair asks if science should be taught in native languages or in the global language of scientific research.
Terahertz Waves Spot Graphene’s Impurities
Scientists report a rapid and contact-less way to measure the purity of graphene.
New Platform Packs A Three-In-One Punch
Photodynamic therapy, radiotherapy, and chemotherapy have been combined in a single therapeutics and diagnostics platform.
Language Learning Starts From The Cradle
Studies suggest that the window of opportunity for language learning and sensitivity is very small.
New “Dimmer Switch” Approach To Tackling Schizophrenia
By modulating rather than completely blocking the dopamine receptor, a new class of drugs could treat schizophrenia with fewer side effects.
Celltrion Files For FDA Approval For Biosimilar Drug
Celltrion predicts that it is one year away from approval for Remsima®, a biosimilar based on an originator drug from Janssen Biotech.
Lactoferrin On Trial To Reduce Iron Deficiencies In Bangladesh
Lactoferrin, an iron-carrying protein involved in the immune response, is being tested for its ability to prevent iron deficiency during pregnancy.
